VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid

Authors

Erica K.M. Reeves, ReveraGen BioPharma Inc, Rockville, MD
Eric P. Hoffman, George Washington UniversityFollow
Kanneboyina Nagaraju, George Washington University
Jesse M. Damsker, ReveraGen BioPharma Inc, Rockville, MDFollow
John M. McCall, ReveraGen BioPharma Inc, Rockville, MD

Document Type

Journal Article

Publication Date

4-15-2013

Journal

Bioorganic and Medicinal Chemistry

Volume

Volume 21, Issue 8

Inclusive Pages

2241-2249

Comments

Erratum in: Bioorganic and Medicinal Chemistry (2013), 22(7), 1664.

APA Citation

Reeves, E. K. M., Hoffman, E. P., Nagaraju, K., Damsker, J. M., & McCall, J. M. (2013). VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid. Bioorganic and Medicinal Chemistry, 21(8), 2241-2249.

Peer Reviewed

1